Correspondence on Letter regarding "Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?".
作者信息
Oh Joo Hyun, Sinn Dong Hyun
机构信息
Department of Medicine, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, Korea.
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
出版信息
Clin Mol Hepatol. 2023 Jul;29(3):820. doi: 10.3350/cmh.2023.0135. Epub 2023 May 19.
Abstract
摘要
相似文献
1
Correspondence on Letter regarding "Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?".关于“肝活检对于识别慢性乙型肝炎免疫耐受期是否必不可少？”的信件往来
Clin Mol Hepatol. 2023 Jul;29(3):820. doi: 10.3350/cmh.2023.0135. Epub 2023 May 19.
2
Letter regarding "Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?".关于“肝活检对于确定慢性乙型肝炎免疫耐受期是否必不可少？”的信函
Clin Mol Hepatol. 2023 Jul;29(3):812. doi: 10.3350/cmh.2023.0132. Epub 2023 May 8.
3
Correspondence on Letter regarding "Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune tolerant phase".关于“血清学免疫耐受期慢性乙型肝炎的长期预后及组织学评估需求”信件的通信
Clin Mol Hepatol. 2023 Apr;29(2):513-515. doi: 10.3350/cmh.2023.0044. Epub 2023 Feb 15.
4
The imitator of immune-tolerant chronic hepatitis B: A killer in disguise.免疫耐受型慢性乙型肝炎的模仿者：一个伪装的杀手。
Clin Mol Hepatol. 2023 Apr;29(2):363-366. doi: 10.3350/cmh.2023.0079. Epub 2023 Mar 9.
5
Letter regarding "Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase".关于“慢性乙型肝炎血清免疫耐受期的长期预后及组织学评估的必要性”的信函
Clin Mol Hepatol. 2023 Apr;29(2):510-512. doi: 10.3350/cmh.2023.0018. Epub 2023 Jan 30.
6
Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase.慢性乙型肝炎血清学免疫耐受期的长期预后和组织学评估的必要性。
Clin Mol Hepatol. 2023 Apr;29(2):482-495. doi: 10.3350/cmh.2022.0322. Epub 2023 Jan 5.
7
Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?肝活检对于识别慢性乙型肝炎免疫耐受期是否必不可少？
Clin Mol Hepatol. 2023 Apr;29(2):367-370. doi: 10.3350/cmh.2023.0054. Epub 2023 Mar 20.
8
Reply to: Correspondence on "Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection".回复：关于“乙肝表面抗原血清学清除对手术切除后乙肝病毒相关肝细胞癌晚期复发的影响”的通信
J Hepatol. 2022 Nov;77(5):1472-1474. doi: 10.1016/j.jhep.2022.07.032. Epub 2022 Aug 18.
9
Letter: fatty liver disease could have been a confounding factor for phase change in patients with chronic hepatitis B in the immune tolerant phase.
Aliment Pharmacol Ther. 2020 Sep;52(6):1093. doi: 10.1111/apt.15973.
10
Letter: fatty liver disease could have been a confounding factor for phase change in patients with chronic hepatitis B in the immune-tolerant phase-authors' reply.
Aliment Pharmacol Ther. 2020 Sep;52(6):1094-1095. doi: 10.1111/apt.16000.
本文引用的文献
1
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.慢性乙型肝炎的预防、诊断和治疗最新进展：美国肝病研究学会2018年乙型肝炎指南
Hepatology. 2018 Apr;67(4):1560-1599. doi: 10.1002/hep.29800.
2
Variability in the upper limit of normal for serum alanine aminotransferase levels: a statewide study.血清丙氨酸氨基转移酶水平正常上限的变异性：一项全州范围的研究。
Hepatology. 2009 Dec;50(6):1957-62. doi: 10.1002/hep.23200.
Zotero 插件